Angela Nguyen Dinh
Palo Alto Investors Lp
Assets Managed
$653.863M
Holdings
51
Last Quarter
2026 - Q1
Filed Date
14d ago
Growth Rate
-8.97%(2Q avg: 11.98%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Palo Alto Investors Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 51 positions.
Assets under management
The assets under management (AUM) of Palo Alto Investors Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 653.863M in assets, with a quarterly growth rate of -8.97% and a 2-quarter average growth rate of 11.98%. The portfolio is managed by Angela Nguyen Dinh, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
INSM Insmed Inc
| 10.39% | $67.905M 415,269 shares@ $163.53 avg price | Decreased -15.16% |
ACAD Acadia Pharmaceuticals Inc
| 9.78% | $63.946M 2.873M shares@ $22.27 avg price | Increased 15.65% |
PTCT Ptc Therapeutics Inc
| 9.61% | $62.789M 921,607 shares@ $68.14 avg price | Increased 1.96% |
BMRN Biomarin Pharmaceutical Inc
| 5.92% | $38.706M 685,182 shares@ $56.49 avg price | Decreased -8.18% |
UTHR United Therapeutics Corp
| 5.7% | $37.244M 62,809 shares@ $592.99 avg price | Increased 7.95% |
ANAB Anaptysbio Inc
| 5.42% | $35.392M 638,161 shares@ $55.46 avg price | Decreased -7.51% |
MIRM Mirum Pharmaceuticals Inc
| 4.6% | $30.04M 325,175 shares@ $92.39 avg price | Increased 107.89% |
DYN Dyne Therapeutics Inc
| 4.59% | $29.968M 1.653M shares@ $18.13 avg price | Increased 12.28% |
BIIB Biogen Inc
| 3.95% | $25.798M 140,719 shares@ $183.33 avg price | Decreased -23.34% |
IRON Disc Medicine Inc
| 3.93% | $25.686M 401,719 shares@ $63.95 avg price | Increased 26.55% |
1-10 of 51